<DOC>
	<DOCNO>NCT02452099</DOCNO>
	<brief_summary>The main aim study evaluate clinical impact different DMSO concentration cryopreservation mixture ( 5 % , 7.5 % , 10 % ) reconstitution hematopoiesis autologous hematopoietic stem cell transplantation .</brief_summary>
	<brief_title>Impact DMSO Concentrations Hematopoietic Recovery After Autologous HSC Transplantation .</brief_title>
	<detailed_description>The procedure autologous hematopoietic stem cell ( HSC ) transplantation require cryopreservation HSCs . Addition DMSO ( dimethyl sulfoxide ) necessary secure viability cell , cryoprotectant potentially toxic stem cell recipient . The concentration DMSO cryopreservation mixture vary strongly protocols different transplant center . Usually , HSCs store mixture contain 10 % DMSO , sufficient evidence concentration DMSO indeed optimal . The main aim study evaluate clinical impact reduction DMSO concentration cryopreservation mixture engraftment autologous hematopoietic stem cell transplantation . 150 consecutive patient randomly assign one three study arm ( 50 patient ) . HSCs obtain leukapheresis cryopreserved three concentration DMSO : 5 % , 7.5 % , 10 % , respectively . Evaluation mixture carry monitor reconstitution hematopoiesis frequency side effect patient . The important aspect evaluation speed neutrophil recovery transplantation ( define first day , absolute neutrophil count peripheral blood high 0.5 G/L ) . The investigator also evaluate toxicity cell suspension monitoring frequency infusion-related adverse event ( like nausea vomit ) infusion 24 hour transplantation .</detailed_description>
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Dimethyl Sulfoxide</mesh_term>
	<criteria>Patients hematological malignancy solid tumor , refer autologous HSC transplantation Written inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>DMSO</keyword>
	<keyword>cryopreservation</keyword>
	<keyword>autologous transplantation</keyword>
	<keyword>hematopoietic stem cell</keyword>
	<keyword>hematological malignancy</keyword>
</DOC>